ABOUT US

ZHONGCHAO INC. (NasdaqCM: ZCMD)

Zhongchao Inc. a holding company incorporated under the laws of the Cayman Islands, through its variable interest entity and subsidiaries, provides healthcare information, education, and training services to healthcare professionals and the public in China. The Company commenced its operation, through Zhongchao Shanghai, in August 2012 with a vision to offer a wide range of accessible and immediate healthcare information and continuous learning and training opportunities for Chinese healthcare professionals.

Stock Chart

News

01 Zhongchao Inc. Announces Hematological Tumor Patient Management Business to Further Expand to Out-of-Hospital Market
Shanghai, China, September [●], 2021 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) (“Zhongchao” or the “Company”), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management platform, today announced its subsidiary Shanghai Zhongxin Medical Technology Co., Ltd. (“Zhongxin”) launches Hematological Tumor Patient Care Center (the “Care Center”), continuing to improve its business ecology in tumor patient management and further expanding to out-of-hospital market. The out-of-hospital market includes extensive online and onsite retail pharmacies and private institutions such as private hospitals and private clinics.
02 Zhongchao Inc. Builds A Patient DOT Management System
Shanghai, China, August 12, 2021 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) (“Zhongchao” or the “Company”), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that its subsidiary Shanghai Zhongxin Medical Technology Co., Ltd. (“Zhongxin”) launches Treatment Outcome Oriented DOT Management System (“DOT Management System”) to accelerate the development of patient management business, meeting the increasing demand in tumor and rare disease patient management market.
03 Zhongchao Inc. Builds A Platform for Breast Cancer Tiered Diagnosis and Treatment Improvement To Promote the Equalization of Breast Cancer Diagnosis and Treatment Level
SHANGHAI, July 27, 2021 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that for the first half of 2021, around 100,000 users had completed the learnings through the Breast Cancer Tiered Diagnosis and Treatment Improvement Platform ("Platform") built and operated by the Company.
04 Zhongchao Inc. Launched New Line of Business Focusing on Tumor and Rare Disease Patient Management
SHANGHAI, May 28, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering online healthcare information, professional training and educational services, announced the launch of the patient management service focusing on the professional field of tumor and rare disease operated through its subsidiary Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin").